ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant

Affiliations

• ¹ Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ² Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany Pediatric Glioma Research, Germany.
• ³ Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
• ⁴ Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.
• ⁵ Department of Neuropathology, University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany.
• ⁶ Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
• ⁷ Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.